![Four big takeaways to wrap up the Paris Air Show [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2023/06/FCAS-scaled-e1685718848105.jpg?#)
![The sights of Paris Air Show, one last time: Day 4 [Photos]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/06/20250617-helenedelacoste-Paris-Air-Show-037-scaled-e1750357690820.jpg?#)
Invivoscribe’s LabPMM secures NYS approval for NPM1 MRD Assay
Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid leukaemia (AML). The post Invivoscribe’s LabPMM secures NYS approval for NPM1 MRD Assay appeared first on Medical Device Network.
Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid leukaemia (AML).
The post Invivoscribe’s LabPMM secures NYS approval for NPM1 MRD Assay appeared first on Medical Device Network.
